Atopic Dermatitis and Difficult-to-Treat Areas: A Case Series of Four Patients With Dupilumab-Resistant Primary Atopic Blepharitis and Successfully Treated With Upadacitinib

Dermatitis. 2024 Jul-Aug;35(4):409-410. doi: 10.1089/derm.2023.0196. Epub 2023 Nov 1.

Authors

Gaetano Licata¹, Vittorio Tancredi², Giulia Calabrese², Mariachiara Arisi³, Cesare Ariasi³, Caterina Mariarosaria Giorgio²

Affiliations

¹ Dermatology Unit, San Antonio Abate Hospital, Trapani, Italy.
² Dermatology Unit, Department of Mental and Physical Health and Preventive Medicine, University of Campania Luigi Vanvitelli, Naples, Italy.
³ Dermatology Department, ASST Spedali Civili di Brescia, University of Brescia, Brescia, Italy.

PMID: 37910788
DOI: 10.1089/derm.2023.0196

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Adult
Antibodies, Monoclonal, Humanized* / therapeutic use
Blepharitis* / drug therapy
Dermatitis, Atopic* / drug therapy
Female
Heterocyclic Compounds, 3-Ring / therapeutic use
Humans
Male
Middle Aged

Substances

dupilumab
Antibodies, Monoclonal, Humanized
upadacitinib
Heterocyclic Compounds, 3-Ring